RecruitingPhase 2NCT05485155

Zemaira Eosinophilic Esophagitis Pilot Study

Studying NON RARE IN EUROPE: Eosinophilic esophagitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Marc Rothenberg
Cincinnati Children's Hospital Medical Center
Intervention
Alpha-proteinase inhibitor(drug)
Enrollment
15 enrolled
Eligibility
18-70 years · All sexes
Timeline
20252027

Study locations (2)

Collaborators

CSL Behring · National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05485155 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Eosinophilic esophagitis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis

← Back to all trials